Variant Creutzfeldt-Jakob disease: An unfolding epidemic of misfolded proteins

Journal of Paediatrics and Child Health

Volumn 38, Issue 6, 2002, Pages 539-542

  Horby, P ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Control; Epidemiology; Pathogenesis; Variant Creutzfeldt Jakob disease

Indexed keywords

PRION PROTEIN;

AGE; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EPIDEMIC; FOOD CONTAMINATION; GENETIC SUSCEPTIBILITY; HUMAN; INCUBATION TIME; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; UNITED KINGDOM; VERTICAL TRANSMISSION; WASTE MANAGEMENT;

CREUTZFELDT-JAKOB SYNDROME; DISEASE SUSCEPTIBILITY; GREAT BRITAIN; HUMANS; PRIONS;

EID: 0036436305     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2002.00055.x     Document Type: Review

References (36)

1. Will RG, Ironside JW, Zeidler M et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-5.
2. Boyd A, Fletcher A, Less JS, Lewis V, Masters CL, Collins SJ. Transmissible spongiform encephalopathies in Australia. Commun. Dis. Intell. 2001; 25: 248-53.
3. Gibbs CJ Jr, Gajdusek DC, Asher DM et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): Transmission to the chimpanzee. Science 1968; 161: 388-9.
4. Prusiner SB. Prions. Proc. Natl. Acad. Sci. USA 1998; 95: 13 363-83.
5. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 1994; 35: 513-29.
6. National CJD Surveillance Unit. Creutzfeldt-Jakob Disease Surveillance in the UK: The Ninth Annual Report. NJDSU, Edinburgh, 2000.
7. Will RG, Zeidler M, Stewart GE et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann. Neurol. 2000; 47: 575-82.
8. Collie DA, Sellar RJ, Zeidler M, Colchester AC, Knight R, Will RG. MRI of Creutzfeldt-Jakob disease: Imaging features and recommended MRI protocol. Clin. Radiol. 2001; 56: 726-39.
9. Wadsworth JD, Joiner S, Hill AF et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358: 171-80.
10. Griffith JS. Self-replication and scrapie. Nature 1967; 215: 1043-4.
11. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-44.
12. Narang H. A critical review of the nature of the spongiform encephalopathy agent: Protein theory versus virus theory. Exp. Biol. Med. (Maywood) 2002; 227: 4-19.
13. Jackson GS, Collinge J. The molecular pathology of CJD: Old and new variants. J. Clin. Mol. Pathol. 2001; 54: 393-9.
14. Stahl N, Baldwin MA, Teplow DB, et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 1993; 32: 1991-2002.
15. Pan KM, Baldwin M, Nguyen J et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 1993; 90: 10 962-6.
16. Rutala WA, Weber DJ. Creutzfeldt-Jakob disease: Recommendations for disinfection and sterilization. Clin. Infect. Dis. 2001; 32: 1348-56.
17. Bueler H, Aguzzi A, Sailer A et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73: 1339-47.
18. Kocisko DA, Come JH, Priola SA et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370: 471-4.
19. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: A case-control study. Lancet 1999; 353: 693-7.
20. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strains and the aetiology of 'new variant CJD'. Nature 1996; 383: 685-90.
21. Bruce ME, Will RG, Ironside JW et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501.
22. Hill AF, Desbruslais M, Joiner S et al. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-50.
23. Scott MR, Will R, Ironside J et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc. Natl. Acad. Sci. USA 1999; 96: 15 137-42.
24. Alperovitch A, Zerr I, Pocchiari M et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999; 353: 1673-4.
25. Huillard d'Aignaux J, Costagliola D, Maccario J et al. Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999; 53: 1197-201.
26. Lee HS, Brown P, Cervenakova L et al. Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J. Infect. Dis. 2001; 183: 192-6.
27. Jackson GS, Beck JA, Navarrete C et al. HLA-DQ7 antigen and resistance to variant CJD. Nature 2001; 414: 269-70.
28. Cousens S, Smith PG, Ward H et al. Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet 2001; 357: 1002-7.
29. Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC. Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J. Infect. Dis. 1980; 142: 205-8.
30. Donnelly CA, Ferguson NM, Ghani AC, Wilesmith JW, Anderson RM. Analysis of dam-calf pairs of BSE cases: Confirmation of a maternal risk enhancement. Proc. R. Soc. Lond. B. Biol. Sci. 1997; 264: 1647-56.
31. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352: 703-4.
32. Brooke FJ. Editorial: Development of Australia's response to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Commun. Dis. Intell. 2001; 25: 99-100.
33. Chief Medical Officer (CMO) for England. Tonsil and adenoid surgery (Letter). Chief Medical Officer Urgent Communication 14 December 2001. Available from: http://www.doh.gov.uk/cmo/cmo01_19.htm
34. Brown P, Cervenakova L, McShane LM, Barber P, Rubenstein R, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999; 39: 1169-78.
35. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000; 356: 999-1000.
36. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358: 208-9.